These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 19519443)

  • 61. The microbes of the intestine: an introduction to their metabolic and signaling capabilities.
    Hsiao WW; Metz C; Singh DP; Roth J
    Endocrinol Metab Clin North Am; 2008 Dec; 37(4):857-71. PubMed ID: 19026936
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Know your neighbor: Microbiota and host epithelial cells interact locally to control intestinal function and physiology.
    Sommer F; Bäckhed F
    Bioessays; 2016 May; 38(5):455-64. PubMed ID: 26990415
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The human gut microbiome as source of innovation for health: Which physiological and therapeutic outcomes could we expect?
    Doré J; Multon MC; Béhier JM;
    Therapie; 2017 Feb; 72(1):21-38. PubMed ID: 28131442
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Connecting the dots: Targeting the microbiome in drug toxicity.
    Luo Y; Zhou T
    Med Res Rev; 2022 Jan; 42(1):83-111. PubMed ID: 33856076
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Nutrition, intestinal defence and the microbiome.
    Kelly P
    Proc Nutr Soc; 2010 May; 69(2):261-8. PubMed ID: 20202280
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Gut microbiota and host metabolism in liver cirrhosis.
    Usami M; Miyoshi M; Yamashita H
    World J Gastroenterol; 2015 Nov; 21(41):11597-608. PubMed ID: 26556989
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Alternative stable states in the intestinal ecosystem: proof of concept in a rat model and a perspective of therapeutic implications.
    Van de Guchte M; Burz SD; Cadiou J; Wu J; Mondot S; Blottière HM; Doré J
    Microbiome; 2020 Nov; 8(1):153. PubMed ID: 33158453
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Utilizing "omics" tools to study the complex gut ecosystem.
    Fodor A
    Adv Exp Med Biol; 2014; 817():25-38. PubMed ID: 24997028
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Intestinal immune response is regulated by gut microbe].
    Tanemoto S; Sujino T; Kanai T
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(6):408-415. PubMed ID: 29367525
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Understanding the role of gut microbes and probiotics in obesity: how far are we?
    Sanz Y; Rastmanesh R; Agostoni C
    Pharmacol Res; 2013 Mar; 69(1):144-55. PubMed ID: 23147032
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effects of the gut microbiota on obesity and glucose homeostasis.
    Greiner T; Bäckhed F
    Trends Endocrinol Metab; 2011 Apr; 22(4):117-23. PubMed ID: 21353592
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Does our food (environment) change our gut microbiome ('in-vironment'): a potential role for inflammatory bowel disease?
    de Wouters T; Doré J; Lepage P
    Dig Dis; 2012; 30 Suppl 3():33-9. PubMed ID: 23295690
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Routine habitat change: a source of unrecognized transient alteration of intestinal microbiota in laboratory mice.
    Ma BW; Bokulich NA; Castillo PA; Kananurak A; Underwood MA; Mills DA; Bevins CL
    PLoS One; 2012; 7(10):e47416. PubMed ID: 23082164
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Host-compound foraging by intestinal microbiota revealed by single-cell stable isotope probing.
    Berry D; Stecher B; Schintlmeister A; Reichert J; Brugiroux S; Wild B; Wanek W; Richter A; Rauch I; Decker T; Loy A; Wagner M
    Proc Natl Acad Sci U S A; 2013 Mar; 110(12):4720-5. PubMed ID: 23487774
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Biochemical Mechanisms of Pathogen Restriction by Intestinal Bacteria.
    Rangan KJ; Hang HC
    Trends Biochem Sci; 2017 Nov; 42(11):887-898. PubMed ID: 28927699
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The gut microbiota ecology: a new opportunity for the treatment of metabolic diseases?
    Burcelin R; Luche E; Serino M; Amar J
    Front Biosci (Landmark Ed); 2009 Jun; 14(13):5107-17. PubMed ID: 19482607
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Therapeutic implications of manipulating and mining the microbiota.
    Shanahan F
    J Physiol; 2009 Sep; 587(Pt 17):4175-9. PubMed ID: 19505978
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Contributions of intestinal bacteria to nutrition and metabolism in the critically ill.
    Morowitz MJ; Carlisle EM; Alverdy JC
    Surg Clin North Am; 2011 Aug; 91(4):771-85, viii. PubMed ID: 21787967
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Host-bacterial mutualism in the human intestine.
    Bäckhed F; Ley RE; Sonnenburg JL; Peterson DA; Gordon JI
    Science; 2005 Mar; 307(5717):1915-20. PubMed ID: 15790844
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Host-microbial interactions in the metabolism of therapeutic and diet-derived xenobiotics.
    Carmody RN; Turnbaugh PJ
    J Clin Invest; 2014 Oct; 124(10):4173-81. PubMed ID: 25105361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.